Pharmacological comparative characterization of rel-1017 (esmethadone-hcl) and other nmdar channel blockers in human heterodimeric n-methyl-d-aspartate receptors

HIGHLIGHTS

• who: Ezio Bettini et al. from the In Vitro Pharmacology Department, Aptuit, An Evotec Company, Verona, Italy Department of Psychiatry, VAMC (SD), University of California, San Diego, CA, USA have published the article: Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate Receptors, in the Journal: (JOURNAL)
• what: In all the experiments, p and amp;lt; 0.05 was considered statistically significant.
• how: To better characterize the potential activity of REL-1017 in_vivo the authors examined its effect in automated whole-cell . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.